出典:Wikipedia
出典:『Wikipedia』 (2010/09/18 20:52 UTC 版)
Apoptone (HE3235), patented by Harbor BioSciences in 2010, is a novel synthetic steroid analog of a dihydrotestosterone metabolite. It has been found to stimulate cell death (apoptosis) in animal models of prostate and breast cancers, and is currently in Phase I/II clinical trials for patients with advanced prostate cancer.